Shilpa Medicare Limited (SHILPAMED) - Total Liabilities
Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has total liabilities worth Rs10.57 Billion INR (≈ $114.27 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SHILPAMED net asset momentum to track the company's year-over-year net asset growth rate.
Shilpa Medicare Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Shilpa Medicare Limited's total liabilities have evolved over time, based on quarterly financial data. See Shilpa Medicare Limited (SHILPAMED) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Shilpa Medicare Limited Competitors by Total Liabilities
The table below lists competitors of Shilpa Medicare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yunnan Salt & Salt Chemical Industry Co Ltd
SHE:002053
|
China | CN¥8.64 Billion |
|
TTW Public Company Limited
BK:TTW
|
Thailand | ฿6.82 Billion |
|
ROMANDE ENERGIE SA
SW:REHN
|
Switzerland | CHF701.99 Million |
|
Shandong Sacred Sun Power Sources Co Ltd
SHE:002580
|
China | CN¥1.62 Billion |
|
Jiangling Motors Corp Ltd
SHE:000550
|
China | CN¥17.79 Billion |
|
OliX PharmaceuticalsInc
KQ:226950
|
Korea | ₩45.29 Billion |
|
China Communications Services Corporation Limited
F:CMW
|
Germany | €87.59 Billion |
|
Henan Thinker Automation
SHG:603508
|
China | CN¥315.73 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Shilpa Medicare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Shilpa Medicare Limited.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shilpa Medicare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shilpa Medicare Limited (2006–2025)
The table below shows the annual total liabilities of Shilpa Medicare Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs9.47 Billion ≈ $102.42 Million |
-26.77% |
| 2024-03-31 | Rs12.93 Billion ≈ $139.86 Million |
+14.49% |
| 2023-03-31 | Rs11.30 Billion ≈ $122.16 Million |
+6.13% |
| 2022-03-31 | Rs10.64 Billion ≈ $115.11 Million |
-9.03% |
| 2021-03-31 | Rs11.70 Billion ≈ $126.54 Million |
+75.22% |
| 2020-03-31 | Rs6.68 Billion ≈ $72.21 Million |
+58.97% |
| 2019-03-31 | Rs4.20 Billion ≈ $45.43 Million |
+0.18% |
| 2018-03-31 | Rs4.19 Billion ≈ $45.35 Million |
-9.24% |
| 2017-03-31 | Rs4.62 Billion ≈ $49.96 Million |
+47.27% |
| 2016-03-31 | Rs3.14 Billion ≈ $33.93 Million |
-8.60% |
| 2015-03-31 | Rs3.43 Billion ≈ $37.12 Million |
+26.48% |
| 2014-03-31 | Rs2.71 Billion ≈ $29.35 Million |
+22.09% |
| 2013-03-31 | Rs2.22 Billion ≈ $24.04 Million |
+45.98% |
| 2012-03-31 | Rs1.52 Billion ≈ $16.47 Million |
+35.88% |
| 2011-03-31 | Rs1.12 Billion ≈ $12.12 Million |
-29.75% |
| 2010-03-31 | Rs1.60 Billion ≈ $17.25 Million |
-1.46% |
| 2009-03-31 | Rs1.62 Billion ≈ $17.51 Million |
+30.03% |
| 2008-03-31 | Rs1.24 Billion ≈ $13.46 Million |
+455.31% |
| 2007-03-31 | Rs224.19 Million ≈ $2.42 Million |
+116.46% |
| 2006-03-31 | Rs103.57 Million ≈ $1.12 Million |
-- |
About Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, … Read more